Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 01 mei 2018 - 22:01
- Statutory name Galapagos N.V.
- Title Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients
|201805010000000021_Star IGUANA Ph2 MOR106.pdf|
|201805010000000021_Start IGUANA Ph2.pdf|
Date last update: 14 November 2018